Generic Name: dapagliflozin/metformin hydrochloride
Brand Name: XigDuo
Manufacturer: AstraZeneca Canada Inc.
Indications: Diabetes Mellitus, Type 2
Submission Type: New
Project Status: Complete
Date Recommendation Issued: July 20, 2016
Recommendation Type: Reimburse with clinical criteria and/or conditions